Objectives Radiopharmaceuticals, since the discovery of the first medical application of radioactive isotope, have been essential therapeutics for the diagnosis and treatment of numerous diseases. Since the Directive 2001/83/EC entered in force, European regulatory authorities have established a harmonised framework to set quality requirements for the industrial production of radiopharmaceuticals. However, little is known about the harmonisation of extemporaneous preparation of radiopharmaceutical preparations (EPRPs) among European countries. In this context, this study aims to provide an overview of the national regulatory framework on the production of EPRPs of five European countries (i.e. UK, Spain, France, Germany and Italy). Methods Five different national regulatory frameworks were compared based on the results of a literature search on electronic databases (i.e. PubMed, Google scholar). Key findings Unlike industrially produced radiopharmaceuticals, the results highlighted that the regulatory framework on EPRPs is still not fully harmonised at the European level and many provisions are regulated by local national laws. Similarities and differences exist among the European countries, both regarding quality standards and educational courses the operators involved in the preparation of EPRPs have to attend. Conclusions The regulatory framework on the EPRPs is still not harmonised at the European level affecting the access to therapies of European citizens who are not equally guaranteed when an extemporaneous radiopharmaceutical has to be prepared to meet their needs.

Radiopharmaceutical preparations : what are the legislative differences across Europe? / M. Giustiniani, U.M. Musazzi, P. Minghetti, D. Paolino. - In: JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH. - ISSN 1759-8885. - 12:3(2021 Sep), pp. 363-368. [10.1093/jphsr/rmab033]

Radiopharmaceutical preparations : what are the legislative differences across Europe?

U.M. Musazzi
Secondo
;
P. Minghetti
Penultimo
;
2021-09

Abstract

Objectives Radiopharmaceuticals, since the discovery of the first medical application of radioactive isotope, have been essential therapeutics for the diagnosis and treatment of numerous diseases. Since the Directive 2001/83/EC entered in force, European regulatory authorities have established a harmonised framework to set quality requirements for the industrial production of radiopharmaceuticals. However, little is known about the harmonisation of extemporaneous preparation of radiopharmaceutical preparations (EPRPs) among European countries. In this context, this study aims to provide an overview of the national regulatory framework on the production of EPRPs of five European countries (i.e. UK, Spain, France, Germany and Italy). Methods Five different national regulatory frameworks were compared based on the results of a literature search on electronic databases (i.e. PubMed, Google scholar). Key findings Unlike industrially produced radiopharmaceuticals, the results highlighted that the regulatory framework on EPRPs is still not fully harmonised at the European level and many provisions are regulated by local national laws. Similarities and differences exist among the European countries, both regarding quality standards and educational courses the operators involved in the preparation of EPRPs have to attend. Conclusions The regulatory framework on the EPRPs is still not harmonised at the European level affecting the access to therapies of European citizens who are not equally guaranteed when an extemporaneous radiopharmaceutical has to be prepared to meet their needs.
radiopharmaceuticals; extemporaneous preparations; European regulatory framework; industrially manufactured radiopharmaceuticals;
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
21-lug-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
2021 - Radiopharmaceutical preparations, what are the legislative differences across Europe.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 174.54 kB
Formato Adobe PDF
174.54 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
draft_Proof_hi.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 296.36 kB
Formato Adobe PDF
296.36 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/859291
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact